Open Beta
MetriLume

US marketsVNRX

SEC-sourced researchBeta

VNRX

VOLITIONRX LTD

Company comparison ↗

Data passport

CIK
0000093314
Exchange
NYSE
Business activity
— · SIC 2835
Financial inputs
6/6
Filing date
Sep 30, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 1,233,511.0000 USD; December 2025: 1,727,384.0000 USD1.7M USD0 USD0December 2024December 2025
VNRX · Exact amounts and source periods · USD
Period endRevenueFiling date
December 20241,233,511.0000Mar 31, 2026
December 20251,727,384.0000Mar 31, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 20251,727,384.0000-23,357,027.0000-19,683,334.00006,901,227.000042,494,038.0000Mar 31, 2026
December 20241,233,511.0000-26,967,836.0000-25,893,624.00009,399,523.000035,507,259.0000Mar 31, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$1.73MDecember 2025Mar 31, 202610-K
Previous period revenueRevenues$1.23MDecember 2024Mar 31, 202610-K
Net incomeNetIncomeLoss-$23.36MDecember 2025Mar 31, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$19.68MDecember 2025Mar 31, 202610-K
Total assetsAssets$6.9MDecember 2025Mar 31, 202610-K
Total liabilitiesLiabilities$42.49MDecember 2025Mar 31, 202610-K

New filings

Explore methodology ↗